肺癌筛查行为影响因素研究进展

李玉婷; 万绍平; 杨中华

doi:10.11847/zgggws1140313

肺癌筛查行为影响因素研究进展

doi: 10.11847/zgggws1140313

1.
成都中医药大学公共卫生学院，四川成都 610072
2.
四川省肿瘤医院·研究所科技部电子科技大学附属肿瘤医院

基金项目: 四川省科技厅项目（2021YFQ0032）

详细信息

作者简介:
李玉婷（2000 – ），女，四川绵阳人，硕士，研究方向：肿瘤健康促进

通讯作者:
万绍平，E-mail：wsp65@vip.163.com

中图分类号: R 730
计量
- 文章访问数: 46
- HTML全文浏览量: 54
- PDF下载量: 19
- 被引次数: 0
出版历程
- 接收日期: 2022-09-14
- 网络出版日期: 2023-03-31
- 刊出日期: 2023-04-10

Progress in researches on influencing factors of lung cancer screening

1.
School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province 610072, China

摘要

摘要: 肺癌发病率和死亡率高，严重危害人们的健康。肺癌筛查可提高早期发现肺癌及早期手术干预治愈的机会。目前，中国肺癌筛查参与率较低，肺癌筛查服务未得到充分利用。中国居民的肺癌筛查行为影响因素尚不清楚。本文主要对国内外肺癌筛查行为影响因素研究现状进行归纳和总结，为中国各地科学制订、实施肺癌筛查方案提供参考。
- 肺癌 /
- 筛查行为 /
- 影响因素
Abstract: High incidence and mortality rate of lung cancer is a serious health problem. Lung cancer screening can improve the chances of early detection and early surgical intervention of lung cancer. Currently, lung cancer screening participation rate in China is low and lung cancer screening services are underutilized. What factors influence the lung cancer screening behavior of our population is unclear. In this paper we summarize current status of research on factors influencing lung cancer screening behavior at home and abroad, and provide references to the development and implementation of lung cancer screening programs in China.
- lung cancer /
- screening behavior /
- influence factor

HTML全文

参考文献(69)

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:A Cancer Journal for Clinicians, 2021, 71(3): 209 – 249. doi: 10.3322/caac.21660
[2]	Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Communications, 2019, 39(1): 1 – 12. doi: 10.1186/s40880-018-0346-4
[3]	张思维, 郑荣寿, 杨之洵, 等. 2000 — 2014年中国肿瘤登记地区肺癌发病年龄变化趋势分析[J]. 中华预防医学杂志, 2018, 52(6): 579 – 585. doi: 10.3760/cma.j.issn.0253-9624.2018.06.005
[4]	郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19 – 28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005
[5]	蔡玥, 严宝湖, 周恭伟. 2011 — 2015年中国肺癌直接经济负担及次均费用分析[J]. 中国卫生统计, 2018, 35(3): 334 – 337.
[6]	曹毛毛, 陈万青. 坚持政府主导推进中国癌症筛查发展[J]. 中国肿瘤, 2021, 30(11): 803 – 805. doi: 10.11735/j.issn.1004-0242.2021.11.A001
[7]	徐望红. 肿瘤流行病学[M]. 上海: 复旦大学出版社, 2017: 327.
[8]	Rex DK, Johnson DA, Lieberman DA, et al. Colorectal cancer preven-tion 2000: screening recommendations of the American College of Gastroenterology[J]. The American Journal of Gastroenterology, 2000, 95(4): 868 – 877.
[9]	The National Lung Screening Trial Research Team. Reduced lung - cancer mortality with low - dose computed tomographic screening[J]. New England Journal of Medicine, 2011, 365(5): 395 – 409. doi: 10.1056/NEJMoa1102873
[10]	Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study[J]. Gastroenterology, 2004, 126(7): 1674 – 1680. doi: 10.1053/j.gastro.2004.02.018
[11]	Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial[J]. JAMA, 2011, 306(17): 1865 – 1873. doi: 10.1001/jama.2011.1591
[12]	苟兰英, 高红飞, 韩解非, 等. 2013年临床肿瘤学重大进展 —— 美国临床肿瘤学会年度报告[J]. 循证医学, 2014, 14(1): 4 – 29. doi: 10.3969/j.issn.1671-5144.2014.01.002
[13]	de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung - cancer mortality with volume CT screening in a randomized trial[J]. New England Journal of Medicine, 2020, 382(6): 503 – 513. doi: 10.1056/NEJMoa1911793
[14]	Field JK, Vulkan D, Davies MPA, et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta - analysis[J]. The Lancet Regional Health - Europe, 2021, 10: 100179. doi: 10.1016/j.lanepe.2021.100179
[15]	Zhou QH, Fan YG, Wu N, et al. Demonstration program of population - based lung cancer screening in China: rationale and study design[J]. Thoracic Cancer, 2014, 5(3): 197 – 203. doi: 10.1111/1759-7714.12078
[16]	Zhao SJ, Wu N. Early detection of lung cancer: low - dose computed tomography screening in China[J]. Thoracic Cancer, 2015, 6(4): 385 – 389. doi: 10.1111/1759-7714.12253
[17]	Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975 – 2014, featuring survival[J]. JNCI: Journal of the National Cancer Institute, 2017, 109(9): djx030.
[18]	Sun JR, Perraillon MC, Myerson R. The impact of medicare health insurance coverage on lung cancer screening[J]. Medical Care, 2022, 60(1): 29 – 36. doi: 10.1097/MLR.0000000000001655
[19]	Viguier J, Morère JF, Pivot X, et al. Fluctuating behavior of the French population in cancer screening: 5th edition of the EDIFICE survey[J]. Current Oncology Reports, 2018, 20(S1): 14. doi: 10.1007/s11912-017-0646-x
[20]	Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000 – 14 (CONCORD - 3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. The Lancet, 2018, 391(10125): 1023 – 1075. doi: 10.1016/S0140-6736(17)33326-3
[21]	Schütte S, Dietrich D, Montet X, et al. Participation in lung cancer screening programs: are there gender and social differences? A systematic review[J]. Public Health Reviews, 2018, 39: 23. doi: 10.1186/s40985-018-0100-0
[22]	Jemal A, Fedewa SA. Lung cancer screening with low - dose computed tomography in the United States – 2010 to 2015[J]. JAMA Oncology, 2017, 3(9): 1278 – 1281. doi: 10.1001/jamaoncol.2016.6416
[23]	Steiling K, Loui T, Asokan S, et al. Age, race, and income are associated with lower screening rates at a safety net hospital[J]. The Annals of Thoracic Surgery, 2020, 109(5): 1544 – 1550. doi: 10.1016/j.athoracsur.2019.11.052
[24]	Rivera MP, Katki HA, Tanner NT, et al. Addressing disparities in lung cancer screening eligibility and healthcare access. an official American thoracic society statement[J]. American Journal of Respiratory and Critical Care Medicine, 2020, 202(7): e95 – e112. doi: 10.1164/rccm.202008-3053ST
[25]	Guichet PL, Liu BY, Desai B, et al. Preliminary results of lung cancer screening in a socioeconomically disadvantaged popula-tion[J]. American Journal of Roentgenology, 2018, 210(3): 489 – 496. doi: 10.2214/AJR.17.18853
[26]	Ali N, Lifford KJ, Carter B, et al. Barriers to uptake among high - risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial[J]. BMJ Open, 2015, 5(7): e008254. doi: 10.1136/bmjopen-2015-008254
[27]	Zeliadt SB, Hoffman RM, Birkby G, et al. Challenges implement-ing lung cancer screening in federally qualified health centers[J]. American Journal of Preventive Medicine, 2018, 54(4): 568 – 575. doi: 10.1016/j.amepre.2018.01.001
[28]	Richmond J, Mbah OM, Dard SZ, et al. Evaluating potential racial inequities in low - dose computed tomography screening for lung cancer[J]. Journal of the National Medical Association, 2020, 112(2): 209 – 214. doi: 10.1016/j.jnma.2019.10.002
[29]	Lake M, Shusted CS, Juon HS, et al. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow - up[J]. BMC Cancer, 2020, 20(1): 561. doi: 10.1186/s12885-020-06923-0
[30]	Li CC, Matthews AK, Rywant MM, et al. Racial disparities in eligibility for low - dose computed tomography lung cancer screening among older adults with a history of smoking[J]. Cancer Causes and Control, 2019, 30(3): 235 – 240. doi: 10.1007/s10552-018-1092-2
[31]	Lin JS, Finlay A, Tu A, et al. Understanding immigrant Chinese Americans' participation in cancer screening and clinical trials[J]. Journal of Community Health, 2005, 30(6): 451 – 466. doi: 10.1007/s10900-005-7280-5
[32]	Barta JA, Shusted CS, Ruane B, et al. Racial differences in lung cancer screening beliefs and screening adherence[J]. Clinical Lung Cancer, 2021, 22(6): 570 – 578. doi: 10.1016/j.cllc.2021.06.003
[33]	Quaife SL, Marlow LAV, McEwen A, et al. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication[J]. Health Expectations, 2017, 20(4): 563 – 573. doi: 10.1111/hex.12481
[34]	Huang JX, Yue N, Wu JW, et al. Screening rate and influential factors of lung cancer with low - dose computed tomography in Asian population: a systematic review and meta - analysis[J]. Journal of Public Health, 2022, 44(2): 246 – 254. doi: 10.1093/pubmed/fdaa225
[35]	Wang GX, Baggett TP, Pandharipande PV, et al. Barriers to lung cancer screening engagement from the patient and provider perspective[J]. Radiology, 2019, 290(2): 278 – 287. doi: 10.1148/radiol.2018180212
[36]	Hoffman RM, Sussman AL, Getrich CM, et al. Attitudes and beliefs of primary care providers in new Mexico about lung cancer screening using low - dose computed tomography[J]. Preventing Chronic Disease, 2015, 12: E108.
[37]	Jonnalagadda S, Bergamo C, Lin JJ, et al. Beliefs and attitudes about lung cancer screening among smokers[J]. Lung Cancer, 2012, 77(3): 526 – 531. doi: 10.1016/j.lungcan.2012.05.095
[38]	Carter-Harris L, Slaven II JE, Monahan PO, et al. Understanding lung cancer screening behaviour using path analysis[J]. Journal of Medical Screening, 2020, 27(2): 105 – 112. doi: 10.1177/0969141319876961
[39]	Quaife SL, Waller J, Dickson JL, et al. Psychological targets for lung cancer screening uptake: a prospective longitudinal cohort study[J]. Journal of Thoracic Oncology, 2021, 16(12): 2016 – 2028. doi: 10.1016/j.jtho.2021.07.025
[40]	Patel D, Akporobaro A, Chinyanganya N, et al. Attitudes to participation in a lung cancer screening trial: a qualitative study[J]. Thorax, 2012, 67(5): 418 – 425. doi: 10.1136/thoraxjnl-2011-200055
[41]	Bui NC, Lee YY, Suh M, et al. Beliefs and intentions to undergo lung cancer screening among Korean males[J]. Cancer Research and Treatment, 2018, 50(4): 1096 – 1105. doi: 10.4143/crt.2017.393
[42]	Lei F, Chen WT, Brecht ML, et al. Health beliefs toward lung cancer screening among Chinese American high - risk smokers: interviews based on Health Belief Model[J]. International Journal of Nursing Sciences, 2022, 9(3): 378 – 388. doi: 10.1016/j.ijnss.2022.06.005
[43]	Monu J, Triplette M, Wood DE, et al. Evaluating knowledge, attitudes, and beliefs about lung cancer screening using crowdsourcing[J]. Chest, 2020, 158(1): 386 – 392. doi: 10.1016/j.chest.2019.12.048
[44]	Sin MK, Ha A, Taylor V. Sociocultural barriers to lung cancer screening among Korean immigrant men[J]. Journal of Community Health, 2016, 41(4): 790 – 797. doi: 10.1007/s10900-016-0154-1
[45]	Carter-Harris L, Brandzel S, Wernli KJ, et al. A qualitative study exploring why individuals opt out of lung cancer screening[J]. Family Practice, 2017, 34(2): 239 – 244.
[46]	Springer SM, McFall A, Hager P, et al. Lung cancer screening: an emerging cancer control issue presents opportunities for an awareness campaign in rural Michigan[J]. Cancer Causes and Control, 2018, 29(12): 1257 – 1263. doi: 10.1007/s10552-018-1080-6
[47]	Athey VL, Suckling RJ, Tod AM, et al. Early diagnosis of lung cancer: evaluation of a community - based social marketing intervention[J]. Thorax, 2012, 67(5): 412 – 417. doi: 10.1136/thoraxjnl-2011-200714
[48]	Murray SR, Murchie P, Campbell N, et al. Protocol for the CHEST Australia Trial: a phase II randomised controlled trial of an intervention to reduce time - to - consult with symptoms of lung cancer[J]. BMJ Open, 2015, 5(5): e008046. doi: 10.1136/bmjopen-2015-008046
[49]	Wildstein KA, Faustini Y, Yip R, et al. Longitudinal predictors of adherence to annual follow - up in a lung cancer screening programme[J]. Journal of Medical Screening, 2011, 18(3): 154 – 159. doi: 10.1258/jms.2011.010127
[50]	Liu B, Dharmarajan K, Henschke CI, et al. State - level variations in the utilization of lung cancer screening among Medicare fee - for - service beneficiaries: an analysis of the 2015 to 2017 physician and other supplier data[J]. Chest, 2020, 157(4): 1012 – 1020. doi: 10.1016/j.chest.2019.11.005
[51]	Braybrook DE, Witty KR, Robertson S. Men and lung cancer: a review of the barriers and facilitators to male engagement in symptom reporting and screening[J]. Journal of Men’s Health, 2011, 8(2): 93 – 99. doi: 10.1016/j.jomh.2011.03.002
[52]	Jessup DL, Glover IV M, Daye D, et al. Implementation of digital awareness strategies to engage patients and providers in a lung cancer screening program: retrospective study[J]. Journal of Medical Internet Research, 2018, 20(2): e52. doi: 10.2196/jmir.8932
[53]	Lewis JA, Petty WJ, Tooze JA, et al. Low - dose CT lung cancer screening practices and attitudes among primary care providers at an academic medical center[J]. Cancer Epidemiology, Biomarkers and Prevention, 2015, 24(4): 664 – 670. doi: 10.1158/1055-9965.EPI-14-1241
[54]	Klabunde CN, Marcus PM, Han PKJ, et al. Lung cancer screening practices of primary care physicians: results from a national survey[J]. The Annals of Family Medicine, 2012, 10(2): 102 – 110. doi: 10.1370/afm.1340
[55]	Byrne MM, Lillie SE, Studts JL. Lung cancer screening in a community setting: characteristics, motivations, and attitudes of individuals being screened[J]. Health Psychology Open, 2019, 6(1): 2055102918819163.
[56]	Ersek JL, Eberth JM, McDonnell KK, et al. Knowledge of, attitudes toward, and use of low - dose computed tomography for lung cancer screening among family physicians[J]. Cancer, 2016, 122(15): 2324 – 2331. doi: 10.1002/cncr.29944
[57]	Carter-Harris L, Gould MK. Multilevel barriers to the successful implementation of lung cancer screening: why does it have to be so hard?[J]. Annals of the American Thoracic Society, 2017, 14(8): 1261 – 1265. doi: 10.1513/AnnalsATS.201703-204PS
[58]	Iaccarino JM, Clark J, Bolton R, et al. A national survey of pulmonologists' views on low - dose computed tomography screening for lung cancer[J]. Annals of the American Thoracic Society, 2015, 12(11): 1667 – 1675.
[59]	Eberth JM, Qiu R, Adams SA, et al. Lung cancer screening using low - dose CT: the current national landscape[J]. Lung Cancer, 2014, 85(3): 379 – 384. doi: 10.1016/j.lungcan.2014.07.002
[60]	陈万青, 李霓, 曹毛毛, 等. 2013 — 2017年中国城市癌症早诊早治项目基线结果分析[J]. 中国肿瘤, 2020, 29(1): 1 – 6.
[61]	雷锐娇, 张美珍, 王乐, 等. 2014 — 2018年浙江省衢州市城市癌症早诊早治项目筛查结果分析[J]. 中国癌症防治杂志, 2021, 13(6): 618 – 623. doi: 10.3969/j.issn.1674-5671.2021.06.08
[62]	林艳苹, 马洁, 封俊, 等. 云南省昆明市城市居民肺癌筛查结果分析[J]. 中国肺癌杂志, 2019, 22(7): 413 – 418. doi: 10.3779/j.issn.1009-3419.2019.07.02
[63]	汪雯, 李辉章, 朱陈, 等. 浙江省2014 — 2015年度居民癌症风险评估及筛查结果分析[J]. 浙江医学, 2016, 38(22): 1795 – 1798, 1814.
[64]	魏东华, 马艳玲, 张娟, 等. 2014 — 2016年合肥市城市居民肺癌筛查率及筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(3): 231 – 236. doi: 10.11904/j.issn.1002-3070.2021.03.007
[65]	于志福, 王晓煜, 何嵘, 等. 2012 — 2017年辽宁地区城市居民肺癌筛查结果分析[J]. 现代预防医学, 2020, 47(13): 2442 – 2445, 2470.
[66]	郭兰伟, 张韶凯, 刘曙正, 等. 河南省城市地区低剂量螺旋CT肺癌筛查依从性及其影响因素分析[J]. 中华流行病学杂志, 2020, 41(7): 1076 – 1080. doi: 10.3760/cma.j.cn112338-20190730-00564
[67]	温艳, 于连政, 杜灵彬, 等. 中国3省城市癌症早诊早治项目地区肺癌高危人群的低剂量螺旋CT筛查依从性及相关因素分析[J]. 中华预防医学杂志, 2021, 55(5): 633 – 639. doi: 10.3760/cma.j.cn112150-20201015-01286
[68]	任冠华, 叶剑飞, 范亚光, 等. 中国天津大港油田LDCT肺癌筛查人群防治知识调查与分析[J]. 中国肺癌杂志, 2014, 17(2): 163 – 170.
[69]	毛阿燕, 石菊芳, 邱五七, 等. 我国城市地区癌症临床筛查服务潜在供方服务意愿调查[J]. 中华流行病学杂志, 2018, 39(2): 150 – 156. doi: 10.3760/cma.j.issn.0254-6450.2018.02.004